Dashboard
Manage Tickers

ATAI ATAI Life Sciences N.V.

Nasdaq atai.life


$ 3.97 $ -0.03 (-0.75 %)    

Monday, 17-Nov-2025 13:21:17 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 606.49 $ 0.36 (0.06 %)
DIA $ 469.79 $ -1.15 (-0.25 %)
SPY $ 669.23 $ -0.50 (-0.07 %)
TLT $ 89.14 $ 0.06 (0.07 %)
GLD $ 374.70 $ 0.67 (0.18 %)
$ 4
$ 3.94
$ 3.96 x 2,135
$ 3.97 x 678
$ 3.86 - $ 4.04
$ 1.15 - $ 6.75
6,028,169
na
1.45B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-17-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-15-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-24-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-30-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

atai-life-sciences-q3-eps-028-misses-012-estimate-sales-749000k-beat-55560k-estimate
ATAI Life Sciences Q3 EPS $(0.28) Misses $...
11/12/2025 12:14:19

ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of ...

atai-beckley-announces-topline-data-from-phase-2b-open-label-extension-study-of-bpl-003-showing-12-mg-dose-administered-eight-weeks-after-03-mg-8-mg-or-12-mg-dose-provided-additional-clinically-meaningful-effects-and-was-generally-well-tolerated
Atai Beckley Announces Topline Data From P...
11/10/2025 12:12:29

analyst-expectations-for-atai-life-sciencess-future
Analyst Expectations For ATAI Life Science...
10/22/2025 20:01:33

canaccord-genuity-maintains-buy-on-atai-life-sciences-raises-price-target-to-14
Canaccord Genuity Maintains Buy on ATAI Li...
10/22/2025 13:50:06

Canaccord Genuity analyst Sumant Kulkarni maintains ATAI Life Sciences (NASDAQ:ATAI) with a Buy and raises the price target ...

reported-earlier-atai-life-sciences-prices-130m-public-offering-of-23725m-common-shares-at-548-per-share-to-advance-clinical-pipeline
Reported Earlier, atai Life Sciences Price...
10/17/2025 05:52:01

atai-life-sciences-announces-proposed-public-offering-terms-not-disclosed
atai Life Sciences Announces Proposed Publ...
10/16/2025 20:13:52

atai-life-sciences-and-beckley-psytech-announces-that-fda-has-granted-breakthrough-therapy-designation-to-their-bpl-003-nasal-spray-for-adults-with-treatment-resistant-depression
atai Life Sciences And Beckley Psytech Ann...
10/16/2025 20:13:51

Breakthrough Therapy designation recognizes the potential of BPL-003 to deliver substantial improvement over existing therapies...

atai-life-sciences-remains-undervalued-analyst-initiates-with-around-125-stock-upside
Atai Life Sciences Remains Undervalued, An...
10/13/2025 18:21:17

Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion s...

Core News & Articles
'Psychedelics Show Promise As An 'Entirely...
10/13/2025 17:28:47

https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-sugge...

needham-initiates-coverage-on-atai-life-sciences-with-buy-rating-announces-price-target-of-12
Needham Initiates Coverage On ATAI Life Sc...
10/13/2025 10:08:07

Needham analyst Ami Fadia initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Buy rating and announces Price Targe...

Core News & Articles
'New York Lawmakers Hold Hearing Psilocybi...
10/02/2025 15:03:14

https://www.marijuanamoment.net/new-york-lawmakers-hold-hearing-psilocybins-medical-benefits-amid-broader-debate-over-psychedel...

atai-life-sciences-nv-says-certain-selling-securityholders-may-offer-and-sell-common-shares-including-up-to-453m-shares-by-selling-securityholders
ATAI Life Sciences N.V. Says Certain Selli...
09/29/2025 21:40:45

-SEC Filing

atai-life-sciences-nv-files-for-potential-mixed-shelf-size-not-disclosed
Atai Life Sciences N.V. Files For Potentia...
09/29/2025 21:33:12

-SEC Filing

alibaba-lithium-americas-and-other-big-stocks-moving-higher-in-wednesdays-pre-market-session
Alibaba, Lithium Americas And Other Big St...
09/24/2025 10:34:48

demystifying-atai-life-sciences-insights-from-5-analyst-reviews
Demystifying ATAI Life Sciences: Insights ...
09/23/2025 22:00:37

atai-life-sciences-experimental-depression-drug-shows-sustained-benefit-in-treatment-resistant-patients
Atai Life Sciences Experimental Depression...
09/23/2025 18:50:10

Atai Life Sciences and Beckley Psytech report strong BPL-003 study results in treatment-resistant depression, with Phase 3 tria...

hc-wainwright--co-reiterates-buy-on-atai-life-sciences-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on ATAI...
09/23/2025 14:56:00

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates ATAI Life Sciences (NASDAQ:ATAI) with a Buy and maintains $15...

atai-life-sciences-and-beckley-psytech-announce-clinical-evidence-supporting-two-dose-induction-of-bpl-003-with-sustained-antidepressant-benefits
Atai Life Sciences And Beckley Psytech Ann...
09/23/2025 11:05:34

 Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients with t...

cathie-woods-ark-bets-big-on-solana-treasury-play-makes-162m-investment-in-brera-holdings-as-stock-explodes-225
Cathie Wood's Ark Bets Big On Solana Treas...
09/19/2025 01:42:06

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and b...

atai-life-sciences-awarded-multi-year-milestone-driven-grant-worth-up-to-114m-by-national-institute-on-drug-abuse-part-of-national-institutes-of-health
atai Life Sciences Awarded Multi-Year, Mil...
09/18/2025 12:11:11

atai Life Sciences (NASDAQ:ATAI) ("atai" or "Company"), a clinical-stage biopharmaceutical company on a mission...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION